Skip to content
healthcare.dev

Lifitegrast

NDC 59651-450, Lifitegrast, for solution, from Aurobindo Pharma Limited.

Product NDC
59651-450
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
FOR SOLUTION
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215063
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-450 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIFITEGRAST50 mg/mL

Pharmacologic classes

Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]; Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]

Package NDCNDC-11Package
59651-450-605965104506060 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1d4b4b61-79da-4b6f-bb19-056d111bf400

Use it

Look up 59651-450 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-450 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-450. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.